Market Size - $2.4 Billion in 2015, Market Growth - CAGR of 9.5%, Market Trends – Growing demand for minimally invasive tests using specimen such as oral fluid and urine
According to the latest research report by IMARC Group, The global sexually transmitted disease (STD) diagnostics market size reached US$ 104.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 159.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.71% during 2024-2032. More Info:- https://www.imarcgroup.com/sexually-transmitted-disease-diagnostics-market
The global lateral flow assay market was valued at $8,351.30 million in 2020 and is projected to reach $13,352.90 million by 2030 registering a CAGR of 4.70% from 2021 to 2030.
Stay up-to-date with latest Insights of In Vitro Diagnostics market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
The global molecular diagnostics market is witnessing a period of profound growth. The growth is coming from different regions and markets. The next five years will witness significant developments in molecular diagnostics such as automation, as well as introduction of a wide range of new products. Molecular Diagnostics involves multiple technologies to identify genetic variations in individual patients. These technologies include PCR, FISH, hybrid capture, sequencing and microarrays. The increase in the aging population and incidences of various chronic diseases are driving the demand of molecular diagnostics world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Growing with a CAGR of 14.64 percent global molecular diagnostics market is expected to double its market size in 2017 from the market of 2012.
The Global Point of Care & Rapid Diagnostics Market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8% from 2022 to 2027.
Growing demand for early disease detection, especially in case of cancer due to increase in awareness levels, and advanced technologies such as DNA sequencing and microarrays as well as use of healthcare IT to facilitate accurate diagnosis is anticipated to enhance molecular diagnostics market growth.
The report presents a detailed analysis of the Herpes diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Herpes definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for Herpes Simplex I/II and Herpes Type VI testing for the following markets: • Hospitals • Commercial/Private Labs • Physician Offices • Public Health Labs
Complete report is spread across 101 pages and available @ http://www.reportsnreports.com/reports/407402-2015-2019-us-diagnostics-market-review-and-outlook.html
A leading business intelligence provider, has released its latest research report, “Non-Hodgkin Lymphoma Therapeutics in Major Developed Markets to 2020 - New Entrants and Promising Pipeline Widen Targeted and Immunotherapeutic Treatment Options”, which provides in-depth insight into the indication. It provides estimates of market size for 2013 along with forecasts until 2020 for the eight major developed markets, which comprises the US, UK, France, Germany, Italy, Spain, Japan and Canada. See Full Report @ bit.ly/1wvLvR8
According to the latest research report by IMARC Group, The global disposable syringes market size reached US$ 15.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 27.4 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. More Info:- https://www.imarcgroup.com/disposable-syringes-market
People with low immunity are more prone to Cryptococcosis infections. According to the Centers for Disease Control and Prevention (CDC), cryptococcosis infections are common in people with a weak immunity (especially those having advanced HIV/AIDS) and in people taking corticosteroids or other medications that weaken immunity. People with HIV & AIDS are very susceptible to all types of infections including cryptococcosis infections. According to the World Health Organisation (WHO), HIV is a major global public health concern and takes claimed 40.1 million (33.6–48.6 million) lives.
Diagnostics & Laboratory Technology Team. ... Issues guidance on specific topics related to medical devices including IVDs. ... Commercial history. Regulatory history.
Antinuclear Antibody Test Market is projected to reach revenue of $2.35billion by 2025, and is estimated to grow at a CAGR of 12.4% during the forecast period 2019-2025. The Antinuclear Antibody test market size, in 2018, is $1.04 billion. Antinuclear Antibody tests are done to evaluate an individual for autoimmune disorders. Antinuclear antibodies (ANA) are produced as an immune response to foreign bodies. Sometimes these ANAs attack the cells within the body which leads to autoimmune disorders such as lupus, scleroderma, and rheumatoid arthritis. These ANAs are also called autoantibodies.
According to the latest research report by IMARC Group, The global blood plasma derivatives market size reached US$ 45.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 74.1 Billion by 2032, exhibiting a growth rate (CAGR) of 5.4% during 2024-2032. More Info:- https://www.imarcgroup.com/blood-plasma-derivatives-market
Apoptosis Market research report gives an insight into Apoptosis Mechanism, by Molecular Pathways, Caspase Activators and Inhibitors, Protease/Proteasome Inhibitors, Bcl-2 Modulators, p53 Modulators and Other. See Full Report @ http://bit.ly/1KdUj5P
According to the latest research report by IMARC Group, The global blood plasma derivatives market size reached US$ 43.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 61.9 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028. More Info:- https://www.imarcgroup.com/blood-plasma-derivatives-market
Stay up-to-date with latest Insights of Rapid Tests market research offered by Allied Market Research. Check how key trends and emerging drivers are shaping this industry growth.
Download Free Research Report PDF @ http://bit.ly/2lz0b9S #SexuallyTransmittedDiseaseTesting #MarketAnalysis Sexually Transmitted Disease (STD) Testing is a medical means of testing, prevention, and treatment of Sexually Transmitted Disease (STD). Full Report Url - http://bit.ly/2k0Z1no
Access Complete Report at - https://www.theinsightpartners.com/reports/antiviral-drug-resistance-market “Antiviral Drug Resistance Market” study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.
This Report provided by GrandResearchStore is about, western blotting market is projected to reach USD 730.7 million by 2021 from USD 574.8 million in 2016, at a CAGR of 4.9% in the next five years (2016 to 2021).
The Global Clinical Microbiology Market Is Projected to reach USD 5.77 Billion by 2021 From USD 3.35 Billion in 2016, at a CAGR of 11.5%, during 2016 to 2021.
For more inquiry on this report @ http://goo.gl/Pc2knb . (This is premium report, pricing for which starts at US$4650 Single User PDF) North America accounted for the largest share and will retain its leading position by 2018. This growth is attributed to the increasing prevalence of lifestyle diseases and spread of various contagious diseases. Asia is the most lucrative region for molecular diagnostics in the next five years, and is poised to grow at a CAGR of 12.2% in the forecast period. The high population base and the improved purchasing power of patients will drive this market.
For more inquiry on this report @ http://goo.gl/Pc2knb . (This is premium report, pricing for which starts at US$4650 Single User PDF) North America accounted for the largest share and will retain its leading position by 2018. This growth is attributed to the increasing prevalence of lifestyle diseases and spread of various contagious diseases. Asia is the most lucrative region for molecular diagnostics in the next five years, and is poised to grow at a CAGR of 12.2% in the forecast period. The high population base and the improved purchasing power of patients will drive this market.
Epo Biomarkers Market, by Biomarker Type (Recombinant Human Erythropoietin, Erythropoietin Alfa, Erythropoietin Beta, Erythropoietin Zeta, Erythropoietin Theta, and Darbepoietin Alfa), by Application (End-stage Renal Disorder, Cancer, Rheumatoid Arthritis, AIDS, Myelodysplastic Syndrome, Neurology, Hematology, and Others), by End User (Diagnostic Centers, Hospitals, and Ambulatory Care and Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study. The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market. Browse Complete Report: https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614
Clinical Validation of Prognostic Biomarkers of Risk and Predictive Biomarkers of Drug Efficacy or Safety Gene Pennello, Ph.D. Team Leader, Diagnostics Devices Branch
I want to, first of all, acknowledge Prime Minister Blair, who will join us by ... Honey Bee (Apis mellifera) Proposal (PDF file) 2/10/02. Paxillus involutus ...
San Francisco Bay area. Non-exclusive and no concerns about market power ... DOJ/FTC Statements of Antitrust Enforcement Policy in Health Care Statements 8 & 9 ...
... Life Science Innovation ... 'The life science innovation lifecycle is marked by more ... The 21st Century Life Science Roadmap, Texas Healthcare ...
OVERVIEW GOMEZ Emmanuel SQUEDIN Thomas LETURGEZ Thibaut DELEPIERRE Alban * * * * Qu est ce que nuclisens EasyQ et NASBA amplification technology * STS catalyzes the ...
Public-Private Product Development Partnerships for Global Health R&D: Issues & Challenges Suerie Moon Giorgio Ruffolo Doctoral Fellow in Sustainability Science
Capital Technology Information Services, Inc. Disease Management Informatics Architecture Framework Presented to Disease Management Challenges Disease Management ...
1. Development cooperation (ODA) Targets. 1970 UN, 2002 Monterrey ... Development cooperation agencies. Specialized research agencies. Intramural researchers ...
Agency for Healthcare Research and Quality. APHA CEI Session November 2006 ... Perforated Appendix Admission Rate. Diabetes Long-term Complication Admission Rate ...
Batterers use drinking as one of many excuses for their violence and as a way to ... costs paid to hospitals, doctors, nursing homes, diagnostic laboratories, ...
Addressing the Barriers to Effective Pain Management and Issues of Opioid Misuse and Abuse Maureen F. Cooney, DNP, FNP Adjunct Faculty, Family Nurse Practitioner Program